Last reviewed · How we verify

NCT06789094: ASCA

Validating the Ain Shams Cognitive Assessment Tool

Not yet recruiting Last updated 23 January 2025
What this trial tests

trial testing Ain Shams University Cognitive Assessment (ASCA) tool in Mild Cognitive Impairment (MCI) in 100 participants. Not yet recruiting.

Timeline
1 February 2025
Primary endpoint
1 May 2025
1 June 2025

Quick facts

Lead sponsorAin Shams University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment100
Start date1 February 2025
Primary completion1 May 2025
Estimated completion1 June 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

60 and older, any sex, with Mild Cognitive Impairment (MCI) or Dementia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The diagnosis of cognitive impairment, including dementia and mild cognitive impairment (MCI), is crucial for timely intervention and management. Various screening tools are available for assessing cognitive function, among which the Mini-Mental State Examination (MMSE), the Addenbrooke's Cognitive Examination (ACE), and the Montreal Cognitive Assessment (MoCA) are widely used. However, the recently developed Ain Shams University Cognitive Assessment (ASCA) has shown promise in detecting early cognitive decline. This study aims to assess the performance of ASCA in diagnosing cognitive impairment against DSM5 criteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment (MCI)

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06789094.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing